Small-aperture intraocular lens
Colin Kerr
Published: Friday, December 7, 2018
AcuFocus has received approval for an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) to conduct a study of its IC-8 small-aperture intraocular lens (IOL).
The IC-8 IOL is a clear monofocal lens with an embedded mini-ring or pinhole in the centre. It is designed to increase a patient’s natural range of vision by extending the focus of light rays that enter the eye.
“Achieving IDE approval was the next milestone as we seek premarket approval in the US,” said Al Waterhouse, AcuFocus Chief Executive Officer.
http://www.acufocus.com
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.